Nan Fung Life Sciences Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 14
Professionals
  • Investments
  • 65
  • Portfolio
  • 33
  • Exits
  • 28
Exits

Nan Fung Life Sciences General Information

Description

Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. The company does direct investments via Pivotal bioVenture Partners funds and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages. The firm has presence in both US and Greater China. It was founded in 2017 and is based in Hong Kong.

Contact Information

Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
PE/Buyout
Primary Office
  • 23rd Floor, Nan Fung Tower
  • 88 Connaught Road C, Central
  • Hong Kong
  • Hong Kong

Nan Fung Life Sciences Investments (65)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Oculis 28-Apr-2021 Later Stage VC 000.00 Biotechnology Generating Revenue 000000 0000000 00.0
000000 000000 10-Mar-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
0000000 27-Jan-2021 00000 00000 00000 Biotechnology Generating Revenue
00000 000000 08-Jan-2021 00000 00000 00000 Pharmaceuticals Generating Revenue
00000000 20-Nov-2020 0000 00000 000.00 Drug Discovery Pre-Clinical Trials 000000 0000000 00.0
000000 00000000000 13-Oct-2020 00000 00000 0000 Other Healthcare Services Generating Revenue
0000000000 03-Sep-2020 00000 00000 Biotechnology Startup
000000 000000 14-Jul-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
Engrail Therapeutics 18-Jun-2020 Early Stage VC 0000 Pharmaceuticals Generating Revenue 00000 00000 00000000
Rallybio 19-May-2020 Early Stage VC 00000 Drug Discovery Generating Revenue 000000 0000000 00.0
You’re viewing 10 of 65 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nan Fung Life Sciences Exits (28)

Company Name Exit Date Exit Type Exit Size
Bolt Biotherapeutics 05-Feb-2021 IPO 00000
00000000 000000000 29-Jan-2021 0000000000
00000000 01-Jan-2021 000000000000000000 00000
000000 00000000000 16-Oct-2020 000 00000
00000 16-Oct-2020 000 00000
0000000 0000000000 19-Aug-2020 000 00000
0000000 000000 24-Jul-2020 000 00000
000000 26-Jun-2020 000 00000
Fusion Pharmaceuticals 26-Jun-2020 IPO 00000
Vaxcyte 12-Jun-2020 IPO 00000
You’re viewing 10 of 28 exits. Get the full list »

Nan Fung Life Sciences Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nan Fung Life Sciences Team (25)

Name Title Deals Funds Boards Office
Peter Tuxen Bisgaard Managing Partner, Pivotal bioVenture Partners & Managing Director 00 0 0 San Francisco, CA
Vincent Cheung Founder, Managing Partner, Pivotal bioVenture Partners and Chairman 0 0 0 San Francisco, CA
Shannon Cheung Managing Partner, Pivotal bioVenture Partners (China) Hong Kong, Hong Kong
Heather Preston MD Managing Partner, Pivotal bioVenture Partners (US) 00 0 0 San Francisco, CA
Robert Hopfner Ph.D Managing Partner, Pivotal bioVenture Partners (US) 00 0 0 San Francisco, CA
You’re viewing 5 of 25 team members. Get the full list »

Nan Fung Life Sciences Co-Investors (209)

Name With Exits Lead Partner Series Industry
Pivotal BioVenture Partners China 8 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
Sofinnova Investments 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
Vivo Capital 0 0 Series chart Industry bar
You’re viewing 5 of 209 co-investors. Get the full list »